Medical Economics August 22, 2025
The partnership will combine Vyome’s health care industry expertise and resources with Embryyo’s medical technology capabilities, with the goal of advancing smart medical devices that could reshape disease management and treatment.
Vyome Holdings Inc. and Embryyo Technologies have signed a memorandum of understanding to collaborate on developing and commercializing AI-enabled medical devices, the companies announced.
The partnership will combine Vyome’s health care industry expertise and resources with Embryyo’s medical technology capabilities, with the goal of advancing smart medical devices that could reshape disease management and treatment.
“Vyome’s vision is to partner with the smartest talent tackling the biggest health care markets along the U.S.-India corridor and across our three pillars of pharma, AI, and medical devices,” Vyome Chairman Krishna Gupta...







